XQuick Search
Clinical outcomes of a new aspheric monofocal intraocular lens
Baha Toygar1, Özge Yabaş Kızıloğlu1, Okan Toygar1, Ali Murat Hacımustafaoğlu21Department of Ophthalmology, Bahcesehir University, Faculty of Medicine, Istanbul, Turkey2Department of Ophthalmology, Goztepe Medical Park Hospital, Istanbul, Turkey
INTRODUCTION: To evaluate the clinical outcomes of a new aberration-free aspheric monofocal intraocular lens (IOL).
METHODS: This single-center retrospective study included eyes of cataract patients implanted with a new aberration-free aspheric IOL. Medical records of patients who were followed for 6 months were reviewed. Data on visual acuity (distance, intermediate and near), refractive error (sphere, cylinder and manifest spherical equivalent [MSE]), contrast sensitivity and adverse events were collected and analyzed.
RESULTS: Thirty-eight eyes of 30 patients with a mean age of 65.7±10.6 years were included in the study. At 6 months postoperative, 100% of the eyes had achieved a corrected distance visual acuity of 0.2 logMAR or better, 89% of the eyes had achieved a corrected intermediate visual acuity of 0.2 logMAR or better and 89% of the eyes had achieved a corrected near visual acuity of J3 or better. Postoperatively, there was a significant reduction in the spherical (p<0.01) and cylindrical (p=0.01) refraction compared to baseline with a mean final MSE of 0.03±0.40 diopters. Postoperative low contrast (10%) visual acuity remained stable (p= 0.54) through follow-up visits with a mean of 0.35±0.17 logMAR at the 6-month visit. There were no adverse events associated with the study IOL.
DISCUSSION AND CONCLUSION: The study IOL was safely implanted without any adverse events and improved visual acuity in cataract surgery patients while preserving visual quality over the 6-month follow-up period. Further studies with larger study groups and long term follow-up are necessary to confirm these results.
Manuscript Language: English
